CDK8 and metastatic neoplasm: Although the primary tumor growth of murine 4T1 cells was not significantly affected by CDK8/19i, Cdk8 knockdown in tumor cells and SNX631 treatment of mice carrying established lung metastases extended the survival of the metastatic disease in this model.